Coagulation Disorders USMLE Step 1 Practice Question
An investigator is conducting a phase 1 trial for a novel epoxide reductase inhibitor with favorable pharmacokinetic properties for cerebrovascular accident prophylaxis. Two days after the trial starts, a subject begins to notice pain and erythema over the right thigh. It rapidly progresses to a purpuric rash with the development of necrotic bullae over the next 24 hours. Laboratory studies show a partial thromboplastin time of 29 seconds, prothrombin time of 28 seconds, and INR of 2.15. Which of the following best describes the pathogenesis of the disease process in the patient?
Answer choices
- ADecreased platelet count
- BIncreased factor VII activity
- CIncreased factor VIII activityCorrect answer
- DDecreased plasmin activity
- EDecreased antithrombin III activity
See the full explanation
Get the correct-answer rationale, why each distractor is wrong, the underlying mechanism, and high-yield associations ā plus adaptive practice that targets your weak areas ā with a free MedBoardPRO account.